Medtronic (MDT) balance sheet and financial health

Health Care Equipment · NYSE · Health Care

$102.32 -0.54% Close Nov 17, 2026 Live

TrendArc score 59 of 100 · Health 6.8 · Momentum 8.6 · Moat 6.1 · scored Nov 17, 2026 · How the score works

Cash and short-term investments less borrowings, April 24, 2026

$18.7 billion more borrowings than cash

Medtronic held $9.2 billion of cash and short-term investments against $27.9 billion of borrowings on April 24, 2026. Its lease liabilities, shown apart from borrowings, were $1.2 billion. In the fiscal year to April 2026 its operating income covered its interest 9.0 times.

Borrowings to equity

0.56

$27.9B of borrowings on $49.5B of equity, Apr 2026

Interest cover

9.0x

operating income over interest, fiscal year to April 2026

Return on invested capital

7.8%

latest quarter to July 2026, annualised; the stock card's measure

Cash and borrowings at each fiscal year end

$10.0B$20.0B$30.0B$40.0B2017201820192020202120222023202420252026Cash and short-terminvestments $9.22BBorrowings $27.9B$10.0B$20.0B$30.0B$40.0B20182020202220242026Cash and short-term investments $9.22BBorrowings $27.9B

What the balance sheet holdsApril 24, 2026

Assets $93.0BCash and short-term investments$9.22BReceivables$6.64BInventory$5.95BOther current assets$2.97BProperty, goodwill and other$68.2BFunded by $93.0BBorrowings$27.9BLease liabilities$1.25BOther liabilities$13.8BMinority interests and other$609MShareholders' equity$49.5BAssets $93.0BCash and short-term investments$9.22BReceivables$6.64BInventory$5.95BOther current assets$2.97BProperty, goodwill and other$68.2BFunded by $93.0BBorrowings$27.9BLease liabilities$1.25BOther liabilities$13.8BMinority interests and other$609MShareholders' equity$49.5B

"Other liabilities" is total liabilities less borrowings and lease liabilities; "Property, goodwill and other" is total assets less the current assets and long-term investments; "Minority interests and other" is the rest of the funding (total assets less liabilities and shareholders' equity), mostly outside owners' stakes in subsidiaries.

Balance sheet, the last 10 fiscal year ends

In billions of US dollars, at each fiscal year end, named by the month it ended. Borrowings are bonds, notes, loans and commercial paper; lease liabilities, operating and finance, are shown apart.
Fiscal year endApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
Assets
Cash and short-term investments9.29.08.08.010.610.810.99.811.213.7
Receivables6.66.56.16.05.65.54.66.26.05.6
Inventory6.05.55.25.34.64.34.23.83.63.3
Other current assets3.02.92.62.42.32.02.22.12.22.2
Total current assets24.823.821.921.723.122.522.022.023.024.9
Long-term investments0.00.00.00.00.00.00.00.00.00.0
Total assets93.091.790.090.991.093.190.789.791.499.9
Liabilities and equity
Current liabilities11.712.910.89.112.48.510.48.510.114.3
Borrowings27.928.525.024.324.126.324.725.325.833.4
Lease liabilities1.21.21.11.10.91.11.0———
Total liabilities43.043.439.639.338.341.539.839.540.649.5
Minority interests and other0.60.00.00.00.00.00.00.00.00.0
Shareholders' equity49.548.050.251.552.651.450.750.150.750.2
Financial health
Cash less borrowings-18.7-19.5-17.0-16.3-13.5-15.5-13.8-15.5-14.5-19.7
Borrowings to equity0.560.590.500.470.460.510.490.510.510.67
Interest cover9.0x8.2x7.2x8.6x10.4x4.8x4.4x4.3x5.8x4.9x

Interest cover is operating income over interest expense, for full fiscal years. Minority interests and other is total assets less total liabilities and shareholders' equity (calculated by TrendArc). Company filings as standardised by Tiingo; borrowings and lease liabilities told apart with the lines the company files on SEC EDGAR, and a dash where the two cannot be told apart. Rebuilt nightly.

Medtronic against its peers

CompanyCash less borrowingsBorrowings to equityInterest coverReturn on invested capital
Edwards LifesciencesEW +$4.05B 0.06 54.2x 10.7%
Idexx LaboratoriesIDXX -$651M 0.45 35.0x 56.0%
GE HealthCareGEHC -$7.12B 0.86 6.3x 11.4%
Boston ScientificBSX -$11.3B 0.47 10.3x 6.4%
StrykerSYK -$11.7B 0.64 8.1x 8.0%
Becton DickinsonBDX -$15.9B 0.69 4.2x 4.0%
MedtronicMDT -$18.7B 0.56 9.0x 7.8%
Abbott LaboratoriesABT -$26.9B 0.60 16.3x 4.5%

Each company's newest balance sheet; borrowings leave lease liabilities out; interest cover for its newest fiscal year; return on invested capital is the stock card's measure. A dash where a measure does not apply.

Next

Follow Medtronic with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Medtronic from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.